About Arctic Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to treat and even prevent some of the world’s most pressing diseases.

We are committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options.

Our portfolio is designed to make a significant impact on diseases with high unmet need, ranging from rare and common forms of dementia to inflammatory skin diseases and autoimmune disorders.

Our Story

Our company was founded by Dr. Hakon Hakonarson in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), which he launched in 2006 and established as the largest pediatric biobank and genomic database in the world. We maintain close research relationships with CAG and the Children’s Hospital of Philadelphia.

We redefine the standard of care

Our approach is built on internal discovery efforts, collaborations with academic institutions, industry partners, and business development initiatives to expand our pipeline. Program selection is driven by the strength of the scientific hypothesis and compelling supporting evidence, ensuring that each initiative redefines the standards of care.

Arctictherapeutics 156 Resized Copy

Some of our research partners

The centered logo shows details about that partner. Drag or swipe to change partners.

Explore more

For our latest news and updates, go check out
The Pulse. If you have additional questions for us or are interested in strategic partnering, contact us below.